Keywords:
Intranasal; Phage; CaEDTA; Combination therapy; Pseudomonas aeruginosa; Lung; Infection; Antibiotic resistance
Abstract:
Given the rise of multidrug-resistant (MDR) Pseudomonas aeruginosa infections, alternative treatments are needed. Anti-pseudomonal phage therapy shows promise, but its clinical application is limited due to the development of resistance and a lack of biofilm penetration.